Literature DB >> 11113008

Retention in the endoplasmic reticulum as a mechanism of dominant-negative current suppression in human long QT syndrome.

E Ficker1, A T Dennis, C A Obejero-Paz, P Castaldo, M Taglialatela, A M Brown.   

Abstract

Mutations in the cardiac potassium channel HERG (KCNH2) cause chromosome 7-linked long QT syndrome (LQT2) characterized by a prolonged QT interval, recurrent syncope and sudden cardiac death. Most mutations in HERG exhibit "loss of function" phenotypes with defective channels either inserted into the plasma membrane or retained in the endoplasmic reticulum. "Loss of function" mutations reduce I(Kr), the cardiac delayed rectifier current encoded by HERG, due to haploinsufficiency or suppression of wild-type function by a dominant-negative mechanism. One explanation for dominant-negative current suppression is that mutant subunits render tetrameric channel complexes non-conducting on co-assembly. In the present paper we describe an alternative mechanism for this phenomenon. We show (1) that the dominant-negative HERG mutation A561V is retained in the endoplasmic reticulum and (2) that wild-type channels are tagged for retention in the ER by co-assembly with trafficking deficient A561V subunits. Thus, in HERG A561V dominant-negative suppression of wild-type function is the result of an acquired trafficking defect. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11113008     DOI: 10.1006/jmcc.2000.1263

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  27 in total

1.  Electrophysiological study of V535M hERG mutation of LQT2.

Authors:  Chunyan Shao; Yan Lu; Mohan Liu; Qi Chen; Yunfeng Lan; Yan Liu; Min Lin; Yang Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-12-16

2.  The ATP-sensitive K(+)-channel (K(ATP)) controls early left-right patterning in Xenopus and chick embryos.

Authors:  Sherry Aw; Joseph C Koster; Wade Pearson; Colin G Nichols; Nian-Qing Shi; Katia Carneiro; Michael Levin
Journal:  Dev Biol       Date:  2010-07-17       Impact factor: 3.582

3.  The G604S-hERG mutation alters the biophysical properties and exerts a dominant-negative effect on expression of hERG channels in HEK293 cells.

Authors:  Jianhua Huo; Yanmin Zhang; Na Huang; Ping Liu; Chen Huang; Xueyan Guo; Wenhui Jiang; Nan Zhou; Andrew Grace; Christopher L H Huang; Aiqun Ma
Journal:  Pflugers Arch       Date:  2008-04-03       Impact factor: 3.657

Review 4.  Emerging concepts in the pharmacogenomics of arrhythmias: ion channel trafficking.

Authors:  William T Harkcom; Geoffrey W Abbott
Journal:  Expert Rev Cardiovasc Ther       Date:  2010-08

5.  RNA interference-based therapeutics for inherited long QT syndrome.

Authors:  Guoliang Li; Shuting Ma; Chaofeng Sun
Journal:  Exp Ther Med       Date:  2015-06-12       Impact factor: 2.447

6.  Molecular determinants of pentamidine-induced hERG trafficking inhibition.

Authors:  Adrienne T Dennis; Lu Wang; Hanlin Wan; Drew Nassal; Isabelle Deschenes; Eckhard Ficker
Journal:  Mol Pharmacol       Date:  2011-11-01       Impact factor: 4.436

7.  Transmembrane voltage potential controls embryonic eye patterning in Xenopus laevis.

Authors:  Vaibhav P Pai; Sherry Aw; Tal Shomrat; Joan M Lemire; Michael Levin
Journal:  Development       Date:  2011-12-07       Impact factor: 6.868

8.  PKA phosphorylation of HERG protein regulates the rate of channel synthesis.

Authors:  Jian Chen; Jakub Sroubek; Yamini Krishnan; Yan Li; Jinsong Bian; Thomas V McDonald
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-02-20       Impact factor: 4.733

9.  Hsp40 chaperones promote degradation of the HERG potassium channel.

Authors:  Valerie E Walker; Michael J H Wong; Roxana Atanasiu; Christine Hantouche; Jason C Young; Alvin Shrier
Journal:  J Biol Chem       Date:  2009-11-25       Impact factor: 5.157

10.  Genotype-phenotype aspects of type 2 long QT syndrome.

Authors:  Wataru Shimizu; Arthur J Moss; Arthur A M Wilde; Jeffrey A Towbin; Michael J Ackerman; Craig T January; David J Tester; Wojciech Zareba; Jennifer L Robinson; Ming Qi; G Michael Vincent; Elizabeth S Kaufman; Nynke Hofman; Takashi Noda; Shiro Kamakura; Yoshihiro Miyamoto; Samit Shah; Vinit Amin; Ilan Goldenberg; Mark L Andrews; Scott McNitt
Journal:  J Am Coll Cardiol       Date:  2009-11-24       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.